Viewing Study NCT02121535

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 10:33 PM

Ignite Modification Date: 2025-12-25 @ 8:05 PM

Study NCT ID: NCT02121535

Status: COMPLETED

Last Update Posted: 2017-04-12

First Post: 2014-04-22

Is NOT Gene Therapy: False

Has Adverse Events: True

Brief Title: Bioequivalence Study of Telmisartan Between T80/A5/H12.5 mg FDC Tablet and T80/A5 mg Tab and H12.5 mg Tab Concomitant Use

Sponsor: Boehringer Ingelheim

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module